Nosocomial bloodstream infections caused by Escherichia coli and Klebsiellapneumoniae resistant to third-generation cephalosporins, Finland, 1999–2013: Trends, patient characteristics and mortality

References

• Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–317.
   PubMed Web of Science ®Google Scholar
• Lyytikainen O, Lumio J, Sarkkinen H, et al. Nosocomial bloodstream infections in Finnish hospitals during 1999–2000. Clin Infect Dis. 2002;35:e14–e19.
   PubMed Web of Science ®Google Scholar
• Gagliotti C, Balode A, Baquero F, et al. Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill. 2011;16:19819.
   PubMedGoogle Scholar
• Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29:996–1011.
   PubMed Web of Science ®Google Scholar
• Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother. 2007;60:913–920.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bano J, Picon E, Gijon P, et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol. 2010;48:1726–1731.
   PubMed Web of Science ®Google Scholar
• de Kraker ME, Davey PG, Grundmann H, BURDEN study group. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011;8:e1001104.
   PubMed Web of Science ®Google Scholar
• Leistner R, Gurntke S, Sakellariou C, et al. Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort. Infection. 2014;42:991–997.
   PubMed Web of Science ®Google Scholar
• Stewardson A, Fankhauser C, De Angelis G, et al. Burden of bloodstream infection caused by extended-spectrum beta-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model. Infect Control Hosp Epidemiol. 2013;34:133–143.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:657–686.
   PubMed Web of Science ®Google Scholar
• Harris AD, Perencevich EN, Johnson JK, et al. Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. Clin Infect Dis. 2007;45:1347–1350.
   PubMed Web of Science ®Google Scholar
• EARS-Net. EARS-Net Database. Sweden: ECDC, (European Centre for Disease Prevention and Control) Stockholm, 2015; [cited 2015 Jan 15]. Available from: http://ecdc.europa.eu/en/activities/surveillance/EARS-Net/database/Pages/database.aspx
   Google Scholar
• Jaakola S, Lyytikäinen O, Rimhanen-Finne R, et al. Infectious diseases in Finland 2013. Annual Report by the National Institute of Health and Welfare, Helsinki, Finland. 2014; [cited 2015 May 14]. Available online at: http://urn.fi/URN:ISBN:978-952-302-194-5.
   Google Scholar
• Garner JS, Jarvis WR, Emori TG. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128–140.
   PubMed Web of Science ®Google Scholar
• Forssten SD, Kolho E, Lauhio A, et al. Emergence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae during the years 2000 and 2004 in Helsinki, Finland. Clin Microbiol Infect. 2010;16:1158–1161.
   PubMed Web of Science ®Google Scholar
• Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40:2153–2162.
   PubMed Web of Science ®Google Scholar
• Nyberg SD, Osterblad M, Hakanen AJ, et al. Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002-2004. Scand J Infect Dis. 2007;39:417–424.
   PubMed Web of Science ®Google Scholar
• Haanpera M, Forssten SD, Huovinen P, Jalava J. Typing of SHV extended-spectrum beta-lactamases by pyrosequencing in Klebsiella pneumoniae strains with chromosomal SHV beta-lactamase. Antimicrob Agents Chemother. 2008;52:2632–2635.
   PubMed Web of Science ®Google Scholar
• Ortega M, Marco F, Soriano A, et al. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother. 2009;63:568–574.
   PubMed Web of Science ®Google Scholar
• ESAC-Net. ESAC-Net Database. Sweden: ECDC, (European Centre for Disease Prevention and Control) Stockholm, 2015; [cited 2015 May 18]. Available from: http://ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/esac-net-database/Pages/database.aspx
   Google Scholar
• de Kraker ME, Wolkewitz M, Davey PG, et al. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother. 2011;66:398–407.
   PubMed Web of Science ®Google Scholar
• Freeman JT, McBride SJ, Nisbet MS, et al. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes. Int J Infect Dis. 2012;16:e371–374.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bano J, Picon E, Gijon P, et al. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis. 2010;50:40–48.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bano J, Alcala JC, Cisneros JM, et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med. 2008;168:1897–1902.
   PubMed Web of Science ®Google Scholar
• Livermore DM, Canton R, Gniadkowski M, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother. 2007;59:165–174.
   PubMed Web of Science ®Google Scholar
• Woodford N, Ward ME, Kaufmann ME, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother. 2004;54:735–743.
   PubMed Web of Science ®Google Scholar
• Freeman JT, Williamson DA, Anderson DJ. When should contact precautions and active surveillance be used to manage patients with multidrug-resistant enterobacteriaceae? Infect Control Hosp Epidemiol. 2012;33:753–756.
   PubMed Web of Science ®Google Scholar